Cargando…
Antiphospholipid Antibodies: Their Origin and Development
Antiphospholipid antibodies (aPL) are a hallmark of the antiphospholipid syndrome (APS), which is the most commonly acquired thrombophilia. To date there is consensus that aPL cause the clinical manifestations of this potentially devastating disorder. However, there is good evidence that not all aPL...
Autores principales: | Lackner, Karl J., Müller-Calleja, Nadine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6698834/ https://www.ncbi.nlm.nih.gov/pubmed/31557996 http://dx.doi.org/10.3390/antib5020015 |
Ejemplares similares
-
Pathogenic lipid‐binding antiphospholipid antibodies are associated with severity of COVID‐19
por: Hollerbach, Anne, et al.
Publicado: (2021) -
Antiphospholipid antibodies: Paradigm in transition
por: Horstman, Lawrence L, et al.
Publicado: (2009) -
The Issue of the Antiphospholipid Antibody Syndrome
por: Oliveira, Dinaldo C., et al.
Publicado: (2020) -
Management of Women with Antiphospholipid Antibodies or Antiphospholipid Syndrome during Pregnancy
por: Lee, Eunyoung Emily, et al.
Publicado: (2021) -
Role of antiphospholipid antibodies in the diagnosis of antiphospholipid syndrome
por: Devreese, Katrien M.J., et al.
Publicado: (2021)